Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The phenotype of Graves' orbitopathy is associated with thyrotropin receptor antibody levels.

Journal of endocrinological investigation - 1 Nov 2023

Sarić Matutinović M, Kahaly G J, Žarković M, Ćirić J, Ignjatović S, Nedeljković Beleslin B

Abstract excerpt

PURPOSE: Graves' orbitopathy (GO) is a specific inflammatory disorder of the orbit characterized by a highly heterogeneous clinical phenotype. The role of thyrotropin receptor antibodies (TSH-R-Ab) has been widely researched, however there is still no evidence that these antibodies have a direct pathogenic role in this pathology. The aim of this study was to examine their relation to the individual clinical...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Autoantibodies
Share to Graves Disease

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Graves Ophthalmopathy

Share to Phenotype

Share to Receptors, Thyrotropin

Share to Thyrotropin

Source

Identifiers

PMID: 37020104
DOI: 10.1007/s40618-023-02085-5

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The phenotype of Graves' orbitopathy is associated with thyrotropin receptor antibody levels.PMID 37020104Read ↗

Relevance of TSH-receptor antibody levels in predicting disease course in Graves' orbitopathy: comparison of the third-generation TBII assay and Mc4-TSI bioassaySemantic proximity Read ↗

Stimulatory Thyrotropin Receptor Antibodies Are a Biomarker for Graves’ OrbitopathySemantic proximity Read ↗

Graves’ orbitopathy as a rare disease in Europe: a European Group on Graves’ Orbitopathy (EUGOGO) position statementSemantic proximity Read ↗

Immunopathogenesis of Graves’ ophthalmopathy: The role of the TSH receptorSemantic proximity Read ↗

Unravelling the pathogenic mechanisms in Graves’ orbitopathySemantic proximity Read ↗

A review of TSHR- and IGF-1R-related pathogenesis and treatment of Graves' orbitopathy.Semantic proximity Read ↗

Pathogenesis of Graves' orbitopathy: a 2010 update.Semantic proximity Read ↗

Current concepts in the molecular pathogenesis of thyroid-associated ophthalmopathy.Semantic proximity Read ↗

Diagnosis and classification of Graves' disease.Semantic proximity Read ↗

Role of the underlying thyroid disease on the phenotype of Graves' orbitopathy in a tertiary referral center.Semantic proximity Read ↗

Expression of Endogenous Putative TSH Binding Protein in Orbit.Semantic proximity Read ↗

Etiopathogenesis of Graves' disease.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.